MediSpend to Moderate HCP Engagements Panel at 2nd Annual Comprehensive Strategies for Managing HCP Interactions Conference
PORTSMOUTH, N.H., Oct. 5, 2018
PORTSMOUTH, N.H., Oct. 5, 2018 /PRNewswire/ -- Michaeline Daboul, MediSpend's CEO & President, will moderate a panel of life sciences industry experts as they discuss the challenges and opportunities surrounding the governance of HCP engagements. The panel will discuss this important topic at CBI's 2nd Annual Comprehensive Strategies for Managing HCP Interactions Conference at 2:45pm on Wednesday, October 10, 2018 in Philadelphia, PA.
"Determine the Governance of HCP Engagements at Your Organization" is an important and relevant challenge facing both pharmaceutical and medical devices companies in this highly regulated industry. Daboul will explore the panelists' experiences in best governance practices for HCP engagements across the organization. Learn best practices from the experts on how to collaborate with business stakeholders for efficient workflow cross-functionally. Additionally, panelists will share challenges and successes with change management and how to utilize this information to improve collaboration across the organization.
"Change management is a team effort and critical to the success of governance around HCP engagements," said Daboul. "Monitoring the critical control points in the end-to-end HCP engagement workflow is essential for success."
CBI's 2nd Annual Comprehensive Strategies for Managing HCP Interactions Conference is solely focused on streamlining the communication, engagement and management between the life sciences industry and HCPs. This must-attend meeting provides open discussions and proven strategies to improve the effectiveness and compliance of healthcare provider interactions. The event will be held at the Sheraton Philadelphia University City in Philadelphia, PA.
MediSpend is a global leader in cloud-based compliance software for the life sciences industry. MediSpend is the compliance system of record for some of the world's largest life sciences companies. We help pharmaceutical, medical device, dental and emerging biotech companies comply with global healthcare laws while reducing risk and lowering costs. The MediSpend Compliance Cloud enables life sciences companies to manage and monitor physician engagement, aggregate and analyze enterprise data and comply with global data privacy and transparency reporting regulations. Our employees are committed to customer success, innovation, and exceptional product development. Our customers are located in the US, Europe, Asia and Latin America. MediSpend is headquartered in Portsmouth, NH, with offices in Minnesota, New York and Pennsylvania. To learn more about MediSpend, visit www.medispend.com.
Director of Marketing, MediSpend
View original content to download multimedia:http://www.prnewswire.com/news-releases/medispend-to-moderate-hcp-engagements-panel-at-2nd-annual-comprehensive-strategies-for-managing-hcp-interactions-conference-300725178.html